These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2494722)

  • 1. The incorporation of boronated substances into melanin in vitro--an experimental model for melanotic melanoma.
    Roberto A; Larsson BS
    Strahlenther Onkol; 1989; 165(2-3):165-7. PubMed ID: 2494722
    [No Abstract]   [Full Text] [Related]  

  • 2. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
    Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ
    Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological efficacy of a boronated porphyrin as measured in cell culture.
    Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG
    Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728
    [No Abstract]   [Full Text] [Related]  

  • 4. Boronated compounds for neutron capture therapy.
    Alam F; Bapat BV; Soloway AH; Barth RF; Mafune N; Adams DM
    Strahlenther Onkol; 1989; 165(2-3):121-3. PubMed ID: 2494714
    [No Abstract]   [Full Text] [Related]  

  • 5. Boronophenylalanine for neutron capture therapy of melanoma.
    Coderre JA; Glass JD; Fairchild RG; Micca P; Kalef-Ezra J
    Strahlenther Onkol; 1989; 165(2-3):215-7. PubMed ID: 2494733
    [No Abstract]   [Full Text] [Related]  

  • 6. First human clinical trial of melanoma neutron capture. Diagnosis and therapy.
    Mishima Y; Ichihashi M; Hatta S; Honda C; Yamamura K; Nakagawa T; Obara H; Shirakawa J; Hiratsuka J; Taniyama K
    Strahlenther Onkol; 1989; 165(2-3):251-4. PubMed ID: 2494743
    [No Abstract]   [Full Text] [Related]  

  • 7. Boronated antibodies for neutron capture therapy.
    Abraham R; Müller R; Gabel D
    Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological efficacy of thermal neutrons using Na2(10)B12H11SH studied in vivo on B-16 mouse melanoma.
    Spryshkova R; Naidenov M; Borisov G; Komkov M; Bratsev V; Serebryakov N; Demidov A
    Strahlenther Onkol; 1989; 165(2-3):213-5. PubMed ID: 2494732
    [No Abstract]   [Full Text] [Related]  

  • 9. Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy.
    Barth RF; Mafune N; Alam F; Adams DM; Soloway AH; Makroglou GE; Oredipe OA; Blue TE; Steplewski Z
    Strahlenther Onkol; 1989; 165(2-3):142-5. PubMed ID: 2494716
    [No Abstract]   [Full Text] [Related]  

  • 10. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro.
    Ziegler W; Sauerwein W; Streffer C
    Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731
    [No Abstract]   [Full Text] [Related]  

  • 11. RBE of thermal neutron capture therapy using 10B1-para-boronophenylalanine for human and B-16 melanoma cells.
    Ichihashi M; Sasase A; Hiramoto T; Mishima Y; Fukuda H; Kobayashi T
    Strahlenther Onkol; 1989; 165(2-3):198-201. PubMed ID: 2494727
    [No Abstract]   [Full Text] [Related]  

  • 12. In situ measurement on 10B concentrations and absorbed dose estimations in human malignant melanoma treated by BNCT.
    Kobayashi T; Kanda K; Mishima Y
    Strahlenther Onkol; 1989; 165(2-3):104-6. PubMed ID: 2494708
    [No Abstract]   [Full Text] [Related]  

  • 13. Plan for synthesis of biomolecules for neutron capture therapy of cervical carcinoma.
    Wongwiechintana C; Choonchartprasert S; Tampitak S; Prachayasittigul S
    Strahlenther Onkol; 1989; 165(2-3):125-6. PubMed ID: 2494715
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced survival in a rat glioma model following BNCT.
    Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN
    Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736
    [No Abstract]   [Full Text] [Related]  

  • 15. Canine spontaneous brain tumors--a large animal model for BNCT.
    Gavin PR; Kraft SL; Wendling LR; Miller DL
    Strahlenther Onkol; 1989; 165(2-3):225-8. PubMed ID: 2494737
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia.
    Sourek K; Tovarys F
    Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741
    [No Abstract]   [Full Text] [Related]  

  • 17. Melanin-affinic thioureas as selective melanoma seekers.
    Larsson BS
    Melanoma Res; 1991; 1(2):85-90. PubMed ID: 1823628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative microscopic study on response of Ehrlich carcinoma to BNCT vs. chemo- and radiotherapy.
    Samarrai SF; al-Mufti AW; Hikmat S; Karim JM; al-Hayani R; Sugano H; Saito T; Tsukagoshi S; Amano K; Hatanaka H
    Strahlenther Onkol; 1989; 165(2-3):217-8. PubMed ID: 2494734
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated approach in the planning of neutron capture therapy.
    Ryabukhin YS
    Strahlenther Onkol; 1989; 165(2-3):158-62. PubMed ID: 2494721
    [No Abstract]   [Full Text] [Related]  

  • 20. Boron chemistry and target cell affinity.
    Soloway AH; Alam F; Barth RF; Bapat BV
    Strahlenther Onkol; 1989; 165(2-3):118-20. PubMed ID: 2494713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.